This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

ONLINE REGISTRATION CLOSES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Eric Janezic, Ph.D.
Principal Scientist at Genentech
Speaker

Profile

Eric obtained his PhD in Pharmacology from the University of Washington studying the regulation of GPCR trafficking. In 2021, he joined the Biochemical and Cellular Pharmacology department at Genentech, where he leads a lab responsible for determining biophysical parameters controlling the interactions of therapeutic candidates on living cells for projects across early- and late-stage research portfolios. In this capacity, Eric is passionate about evaluating and implementing cutting edge technologies that will address complex challenges in his field of expertise.

Agenda Sessions

  • A Novel, Label-free Assay to Determine the Binding Kinetics of Therapeutic Antibodies on Living Cells

    11:00am